China's Fosun Pharma Takes On Roche with Biosimilar Launch

(Bloomberg) -- After nearly two decades of dominance in treating lymphoma in China, Roche Holding AG is about to face direct competition from a Chinese drugmaker offering a cheaper alternative.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.